作者:Brian E. Fink、Gregory D. Vite、Harold Mastalerz、John F. Kadow、Soong-Hoon Kim、Kenneth J. Leavitt、Karen Du、Donald Crews、Toomas Mitt、Tai W. Wong、John T. Hunt、Dolatrai M. Vyas、John S. Tokarski
DOI:10.1016/j.bmcl.2005.07.027
日期:2005.11
A novel series of dual EGFR and HER2 inhibitors based on the pyrrolo[2,1-f][1,2,4]triazine nucleus is described. A general route toward their synthesis, which enables functionalization at multiple sites, has been developed. Biological evaluation in enzymatic and cell-based assays has identified a series of C-6 carbamates with potent biochemical and cellular activities.